Aligos Therapeutics Expands Licensing Agreement with Luxna Biotech in Oligonucleotide Technology to Include Novel Coronavirus ...
SOUTH SAN FRANCISCO, Calif., April 15, 2020 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc., a preclinical stage biotechnology company focused on the development of targeted therapies for hepatologic diseases and viral infections, including chronic hepatitis …